| Title | THERAPEUTIC DRUG MONITORING OF LOPINAVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN RECEIVING ADULT TABLETS: THERAPEUTIC DRUG MONITORING OF LOPINAVIR TABLETS GIVEN TO CHILDREN. | | Author(s) | Puthanakit T, Chokephaibulkit K, Suntarattiwong P, Gorowara M, Vanprapar N, Leawsrisuk P, Suwanlerk T, Boonrak P, Ruxrungtham K | | Institution | From the *HIVNAT, Thai red cross AIDS Research center, Bangkok, Thailand; daggerDivision of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; double daggerDepartment of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; section signQueen Sirikit National Institute of Child Health, Ministry of Public Health, Bangkok, Thailand; and paragraph signDivision of Allergy and Clinical Immunology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand. | | Source | Pediatr Infect Dis J 2009 Oct 24. | | Abstract | Because of the lack of a lopinavir/ritonavir (LPV/r) pediatric formulation, 54 HIV-infected children were given generic LPV/r adult tablets. Of 54 children, 21 took cut pills to get the appropriate dose. The median (interquartile range) LPV trough serum concentration (Ctrough) was 6.7 (5.0-9.9) mg/L. All the children had Ctrough >1.0 mg/L and 96% had values >4.0 mg/L. LPV/r adult tablets can be used in children when it is necessary. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19858772 |
|
